Document is current
Any future updates will be listed below
-
Authors
De Castro, Beatriz Alonso
Rendo, Cristina Reboredo
Mosele, Fernanda
López, Eva Pérez
Martínez, Lourdes Calvo
Novoa, Silvia Antolín
-
Funding
Funding for this research was provided by:
Spanish Society of Medical Oncology
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Can we use HER2DX to modulate treatment intensity in HER2 positive early breast cancer?
Journal Title: Revista de Senología y Patología Mamaria
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.senol.2024.100659
Content Type: article
Copyright: © 2024 SESPM. Published by Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
